Cardiology Letters 2013, 22(3):228-233
Significance of baroreflex sensitivity in advanced heart failure
- 1 Klinika kardiológie UPJŠ LF a VÚSCH a.s., Košice, Slovenská republika
- 2 Department of Cardiology, Duisburg, Germany
Baroreflex sensitivity as an indirect marker of sympatho-parasympathetic interaction provides information about the level of autonomic nervous system dysfunction, which significantly contributes to development and progression of heart failure.
Aim: Our objective was to evaluate the clinical significance of spontaneous baroreflex sensitivity (BRS) in patients with chronic heart failure of ischaemic and nonischaemic etiology, and to evaluate BRS in patients with heart failure and other associated comorbidities (diabetes mellitus, chronic kidney disease).
Methods: We examined 40 patients (13 women and 27 men) with diagnosis of chronic heart failure and sinus rhythm during examination. Average age of the group was 60 ± 11.4 years. For the recording of continuous changes of blood pressure and heart rate we used COLIN CBM-7000, the noninvasive monitor. Examination consisted of two measurements, each of them lasted 5 minutes. The resulting value of baroreflex sensitivity was obtained by averaging these two measurements.
Results: Average value of BRS in the whole group was 6.8 ± 2.7 ms/mmHg, without gender significance (men vs women 6.7 ± 2.7 vs. 7.0 ± 2.8 ms/mmHg). By linear regressive analysis we found positive correlation between BRS and left ventricular ejection fraction (LVEF) (r2 = 0.426). BRS values were significantly lower in patients with LVEF < 30% in comparison to patients with LVEF ≥ 30% (5.5 ± 2.5 vs 7.9 ± 2.3 ms/mmHg; p < 0.05). We found no significant difference between patients with ischaemic and nonischaemic origin of heart failure (6.6 ± 2.8 vs 7.0 ± 2.6 ms/mmHg). Diabetics had significantly lower BRS when compared to nondiabetic patients (4.7 ± 2.0 vs 7.6 ± 2.5 ms/mmHg; p < 0.01). BRS in comparison with symptoms of heart failure had a decreasing tendency with the highest values in class NYHA II up to the lowest values in class NYHA IV (7.7 ± 2.7 vs 4.8 ± 0.2 ms/mmHg; p < 0.01). In the group of patients with chronic kidney disease (CKD) the value of BRS was significantly lower than in patients without CKD (3.2 ± 0.9 ms/mmHg vs 7.3 ± 2.5 ms/mmHg; p < 0.01). We found no influence of cardiovascular drugs on BRS values.
Conclusion: In our study of patients with advanced heart failure (candidates for cardiac resynchronization therapy or heart transplant) we found lower values of BRS in patients with lower LVEF regardless of its etio logy: in higher NYHA class, in diabetics and patients with CKD.
Keywords: baroreflex sensitivity; etiology; chronic heart failure
Published: March 1, 2013 Show citation
References
- Bonow RO, Mann DL, Zipes DP, et al. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: Elsevier; PA 2011:2048.
- Čelovská D, Staško J, Gonsorčík J, et al. Klinický význam senzitivity baroreflexu u pacientov s artériovou hypertenziou. Cardiol 2009;18(3):99-107.
- Kvasnička J, Havlíček A. Arytmologie pro praxi. Praha: Galén; 2010:155.
- Zipes DP, Libby P, Bonow RO, et al. Braunwald´s heart disease: A textbook of cardiovascular medicine. Philadelphia: WB Saunders; PA 2005:2183.
- Rostagno C, Galanti G, Felici M, et al. Prognostic value of baroreflex sensitivity assessed by phase IV of Valsalva manoeuvre in patients with mild-to-moderate heart failure. Eur J Heart Fail 2000;2(1):41-45.
Go to original source... - Staško J, Farkaš A, Čelovská D, et al. Existuje rozdiel medzi senzitivitou baroreflexu u pacientov s ischemickým a neischemickým srdcovým zlyhávaním? Cardiol 2008;17(4):149-156.
- La Rovere MT, Pinna GD, Maestri R, et al. Prognostic implications of baroreflex sensitivity in heart failure patients in the betablocking era. J Am Coll Cardiol 2009;53(2):193-199.
Go to original source... - Dawson SL, Robinson TG, Youde JH, et al. Older subjects show no age-related decrease in cardiac baroreceptor sensitivity. Age Ageing 1999;28(4):347-353.
Go to original source... - Mortara A, La Rovere MT, Pinna GD, et al. Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation 1997;96(10):3450-3458.
Go to original source... - Okada N, Takahashi N, Yufu K, et al. Baroreflex sensitivity predicts cardiovascular events in patients with type 2 diabetes mellitus without structural heart disease. Circ J 2010;74(7):1379-1383.
Go to original source... - Berbari AE, Mancia G. Cardiorenal syndrome: Mechanisms, risk and treatment. Milan: Springer; 2010:320.
Go to original source... - Rubinger D, Backenroth R, Sapoznikov D. Restoration of baroreflex function in patients with end-stage renal disease after renal transplantation. Nephrol Dial Transplant 2009;24(4):13051313.
Go to original source... - La Rovere MT, Bigger JT, Marcus FI, et al. Baroreflex sensitivity and heart variability in prediction of total cardiac mortality after myocardial infarction. The Lancet 1998;351(9101):478-484.
Go to original source... - Gonsorcik J, Olexa P, Farkas A. Usefulness and clinical significance of spontaneous baroreflex sensitivity in patients after myocardial infarction. Int J Cardiol 2002;82(Suppl.1):23.
- De Tommasi E, Iacoviello M, Romito R, et al. Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. Am Heart J 2003;146(5):854.
Go to original source... - Hikosaka M, Yuasa F, Yuyama R, et al. Candesartan and arterial baroreflex sensitivity and sympathetic nerve activity in patients with mild heart failure. J Cardiovasc Pharmacol 2002;40(6):875880.
Go to original source... - Gademan MGJ, Van Bommel RJ, Borleffs CJW, et al. Biventricular pacing-induced acute response in baroreflex sensitivity has predictive value for midterm response to cardiac resynchronization therapy. Am J Phisiol Heart Circ Physiol 2009;297(1):233237.
Go to original source...

